MedPath

The Randomized Controlled Trial Evaluating Utility of Catheter Ablation Us ing ExTRa mapping for Atrial Fibrillatio

Phase 4
Conditions
Atrial fibrillation
D001281
Registration Number
JPRN-jRCT1052210026
Lead Sponsor
Shizuta Satoshi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

First time ablation procedure for persistent atrial fibrillation
Patients who can be followed for at least 1-year after procedure
Patients from who we get written informed consent

Exclusion Criteria

Patients whose atrial fibrillation was restored after only pulmonay veins isolation
Patients who received ablation procedure or MAZE procedure for for atrial fibrillation before enrollment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath